NO20065518L - Behandling eller forebyggelse av respiratoriske virusinfeksjoner med immunmodulerende forbindelser. - Google Patents

Behandling eller forebyggelse av respiratoriske virusinfeksjoner med immunmodulerende forbindelser.

Info

Publication number
NO20065518L
NO20065518L NO20065518A NO20065518A NO20065518L NO 20065518 L NO20065518 L NO 20065518L NO 20065518 A NO20065518 A NO 20065518A NO 20065518 A NO20065518 A NO 20065518A NO 20065518 L NO20065518 L NO 20065518L
Authority
NO
Norway
Prior art keywords
prevention
treatment
viral infections
immunomodulatory compounds
respiratory viral
Prior art date
Application number
NO20065518A
Other languages
English (en)
Inventor
Andrey S Simbirtsev
Alfred R Rudolph
Cynthia W Tuthill
Alexander A Kolobov
Aleksander Petrov
Original Assignee
Sciclone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc filed Critical Sciclone Pharmaceuticals Inc
Publication of NO20065518L publication Critical patent/NO20065518L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En immunmodulerende forbindelse administreres til en pasient som har eller risikerer å få en respiratorisk vimsinfeksjon.
NO20065518A 2004-05-14 2006-11-29 Behandling eller forebyggelse av respiratoriske virusinfeksjoner med immunmodulerende forbindelser. NO20065518L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57094104P 2004-05-14 2004-05-14
PCT/US2005/016595 WO2005112639A2 (en) 2004-05-14 2005-05-12 Treatment or prevention of respiratory viral infections with immunomodulator compounds

Publications (1)

Publication Number Publication Date
NO20065518L true NO20065518L (no) 2006-11-29

Family

ID=35428773

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065518A NO20065518L (no) 2004-05-14 2006-11-29 Behandling eller forebyggelse av respiratoriske virusinfeksjoner med immunmodulerende forbindelser.

Country Status (17)

Country Link
US (1) US20070087974A1 (no)
EP (1) EP1748783A4 (no)
JP (1) JP2007537280A (no)
KR (1) KR20070012522A (no)
CN (1) CN1964731A (no)
AU (1) AU2005244826B2 (no)
BR (1) BRPI0511107A (no)
CA (1) CA2566062A1 (no)
EA (1) EA011954B1 (no)
IL (1) IL179046A0 (no)
MX (1) MXPA06013050A (no)
NO (1) NO20065518L (no)
NZ (1) NZ551457A (no)
SG (1) SG169362A1 (no)
UA (1) UA92586C2 (no)
WO (1) WO2005112639A2 (no)
ZA (1) ZA200610454B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0517401A (pt) 2004-10-27 2008-10-14 Sciclone Pharmaceuticals Inc tratamento ou prevenção de infecções hemorrágicas virais com compostos imunomoduladores
WO2006116053A1 (en) * 2005-04-22 2006-11-02 Sciclone Pharmaceuticals, Inc. Immunomodulator compounds as vaccine enhancers
NZ579570A (en) 2007-02-13 2012-02-24 Sciclone Pharmaceuticals Inc Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
RU2007118237A (ru) * 2007-05-17 2008-11-27 ООО "Научно-производственна фирма Верта" (RU) Способ лечения аллергических заболеваний
RU2438694C1 (ru) * 2010-12-23 2012-01-10 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") Фармацевтическая композиция для лечения вирусных заболеваний

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
RU2229892C2 (ru) * 2001-06-08 2004-06-10 Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" Способ лечения туберкулеза легких

Also Published As

Publication number Publication date
NZ551457A (en) 2009-12-24
AU2005244826A1 (en) 2005-12-01
IL179046A0 (en) 2007-03-08
BRPI0511107A (pt) 2007-11-27
WO2005112639A2 (en) 2005-12-01
AU2005244826B2 (en) 2010-07-29
UA92586C2 (ru) 2010-11-25
EP1748783A4 (en) 2009-08-05
EP1748783A2 (en) 2007-02-07
KR20070012522A (ko) 2007-01-25
MXPA06013050A (es) 2007-03-28
CA2566062A1 (en) 2005-12-01
US20070087974A1 (en) 2007-04-19
CN1964731A (zh) 2007-05-16
SG169362A1 (en) 2011-03-30
EA200602073A1 (ru) 2007-06-29
WO2005112639A3 (en) 2006-11-09
JP2007537280A (ja) 2007-12-20
ZA200610454B (en) 2009-07-29
EA011954B1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
NO20090595L (no) Ny pyridazinforbindelse og anvendelse derav
TW200733953A (en) Materials and methods for treating viral infections
EA201290882A1 (ru) Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
NO20076245L (no) Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner
NO20065518L (no) Behandling eller forebyggelse av respiratoriske virusinfeksjoner med immunmodulerende forbindelser.
NO20072601L (no) Azaindolkarboksamider
WO2008097599A3 (en) Antimicrobial blood pressure cuff liner
CL2011000571A1 (es) Uso de una combinacion de: a) un compuesto de formula (1) o una sal farmaceuticamente aceptable del mismo, b) interferon alfa y c) ribavirina para preparar un medicamento util para el tratamiento de una infeccion viral de la hepatitis c (hcv) o para aliviar uno o mas sintomas de la misma.
MX2009006764A (es) Pirimidinonas biciclicas y usos de la misma.
PH12015501560A1 (en) Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
NO20064964L (no) Behandling av svekket respiratorisk funksjon
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
BRPI0412459A (pt) composto tendo ação anti-hcv e seu método de produção
NO20072498L (no) Behandling eller forebyggelse av blodende virale infeksjoner med immunmodulatorforbindelse
WO2009023356A3 (en) Materials and methods for treating influenza infections
SE0200198D0 (sv) New use
EP2606885A4 (en) "RENESSANS" MEDICINAL PREPARATION WITH ANTIBACTERIAL, ANTI-ULCER AND IMMUNOMODULATORY ACTION
DK1924255T3 (da) Anvendelse af N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamin (OMIGAPIL) til profylakse og/eller behandling af muskeldystrofi
WO2011046901A3 (en) Broad spectrum antiviral and methods of use
WO2006076169A3 (en) Treatment or prevention of genital viral infections with immunomodulator compounds
ATE473737T1 (de) Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application